相似文献
1
Low-molecular-weight heparin for treating venous thromboembolism.
Ann Intern Med. 1999 Jan 5;130(1):77-8. doi: 10.7326/0003-4819-130-1-199901050-00024.
2
Low-molecular-weight heparin for initial treatment of venous thromboembolism.
Am Fam Physician. 2005 Jul 1;72(1):75-6.
3
Venous thromboembolism: a guide to prevention and treatment.
Nurse Pract. 2005 Aug;30(8):26-9, 32-4, 39-43; quiz 44-5. doi: 10.1097/00006205-200508000-00006.
4
Venous thromboembolism and pregnancy.
Obstet Gynecol Clin North Am. 2001 Sep;28(3):613-30. doi: 10.1016/s0889-8545(05)70222-9.
5
Thromboembolism.
Clin Evid. 2005 Dec(14):198-215.
6
Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.
Thromb Haemost. 2001 Oct;86(4):980-4.
7
For the initial treatment of venous thromboembolism: are all low-molecular-weight heparin compounds the same?
Thromb Res. 2000 Oct 15;100(2):V121-30. doi: 10.1016/s0049-3848(00)00272-3.
8
Thromboembolism.
Clin Evid. 2004 Dec(12):285-308.
9
Thromboembolism.
Clin Evid. 2003 Dec(10):273-88.
10
Treatment of venous thromboembolism: experience with bemiparin.
Pathophysiol Haemost Thromb. 2002 Sep-Dec;32(5-6):406-7. doi: 10.1159/000073611.
Zotero 插件